Zalicus (ZLCS)

0.95 -0.01  -1.04%  May 31, 8:00PM Go Pro
Watch this stock
View Full Chart ZLCS Price Chart

Key Stats

Market Cap 99.52M
Revenue Growth 82.53%
Profit Margin -583.7%
Earnings Yield -46.32%
Dividend Yield 0.00%
Earnings Per Share TTM -0.44
PE Ratio
Price / Sales Ratio 10.78
52 Week High 2.90
52 Week Low 0.715
Beta
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 31 $zlcs by Desertblizzard
May 31 $ZLCS Mentioned more than normal on StockTwits - Currently at 2 x average daily social activity by TradeIdeasQuant
May 31 $ZLCS The forcast on this thing looks great. Shows lots of upside. by Lucasm82
May 31 finally added $ZLCS...been window shopping for a while w/ this one. by casualtrader
May 31 $ZLCS Vanguard holdings of over 1 miliion shares is a strong indicator of good things to come.... by jeremykillmer
May 31 $GNOM, $ZLCS, $ABIO, $GALE, $PACB, $CLSN just acquired 100,000 shares of each i need some positive movement here... by Sterac
May 31 $CHTP Sold at 1.43 and bought into $ZLCS. by Lucasm82
May 30 2nd consecutive big day. Truck full of gold loaded.Haaaa. I love $SAPE, $AMRN,$ZLCS. I hate $ZNGA,$ROSG scam stocks. Loaded truck to $ARNA by SamRocks
May 30 RT @ACInvestorBlog $ZLCS looks like it wants to clear the $1 price level very soon by gabbs
May 30 $ZLCS looking good in some terrible tape by ntp112
May 29 Bulls Buy Zalicus As Novartis Collaboration Gains Traction
May 24 ZALICUS INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May 24 Zalicus Is Locked And Loaded: What You Need To Know
May 24 Why Buying 'Market Outperform' Zalicus At A Discount Is Savvy
May 18 [video] Friday Sector Laggards: General Contractors & Builders, Biotechnology Stocks

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Zalicus is down 62.89% over the last year vs S&P 500 Total Return down 0.41%, Savient Pharmaceuticals down 91.11%, and BioDelivery Sciences International down 0.28%.

  • ZLCS Total Returns
  • ^SPXTR Total Returns
  • SVNT Total Returns
  • BDSI Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring ZLCS

Did Zalicus make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

ZLCS Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
ZLCS 0.95 -0.01 -1.04% 99.52M
ZLC 2.34 -0.12 -4.88% 75.37M
ZIXI 2.46 -0.09 -3.53% 154.68M
ZIPR 1.49 +0.07 +4.93% 30.63M
ZIP 10.75 +0.40 +3.86% 426.45M
ZIOP 5.14 +0.12 +2.39% 408.48M
ZION 18.51 -0.52 -2.73% 3.504B
ZINC 8.86 -0.17 -1.88% 387.36M
ZIGO 16.58 -0.33 -1.95% 301.26M
ZHNE 0.84 -0.06 -6.67% 25.91M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close